Pekka A. Saikku

Q: What Schools Are Affiliated With Pekka A. Saikku

Pekka A. Saikku is affiliated with the following schools: University of Oulu, University of Helsinki

Pekka A. Saikku's AcademicInfluence.com Rankings

Pekka A. Saikku

Philosophy

#8042

World Rank

#11347

Historical Rank

Logic

#5076

World Rank

#6436

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Pekka A. Saikku's Degrees

PhD Medical Sciences University of Helsinki
Doctorate Medicine University of Helsinki

Why Is Pekka A. Saikku Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Pekka A. Saikku's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION (1988) (1697)
Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. (1992) (841)
Viruses and Bacteria in the Etiology of the Common Cold (1998) (722)
Etiology of community‐acquired pneumonia in 254 hospitalized children (2000) (648)
Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines (2001) (541)
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. (2001) (419)
Infections, inflammation, and the risk of coronary heart disease. (2000) (364)
Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community (2001) (329)
Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. (2001) (328)
Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. (1997) (306)
Chlamydia Pneumoniae‐Specific Circulating Immune Complexes in Patients With Chronic Coronary Heart Disease (1993) (303)
An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. (1985) (274)
Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits (1997) (262)
Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. (1991) (257)
Evidence for infectious agents in cardiovascular disease and atherosclerosis. (2002) (253)
Association of chlamydial infection with cerebrovascular disease. (1996) (236)
Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. (1996) (234)
Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland. (1988) (223)
Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. (1997) (209)
An epidemic of infections due to Chlamydia pneumoniae in military conscripts. (1993) (192)
Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. (2001) (181)
Association of Helicobacter pylori infection with elevated serum lipids. (1999) (174)
The epidemiology and significance of Chlamydia pneumoniae. (1992) (166)
The genus-specific antigen of Chlamydia: resemblance to the lipopolysaccharide of enteric bacteria. (1983) (161)
Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery. (2000) (157)
Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. (1997) (154)
Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment. (1995) (152)
Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors (2007) (151)
Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae. (1996) (147)
Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. (2000) (141)
Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia. (1996) (140)
Chlamydia pneumoniae Infection in Human Monocytes (1999) (136)
The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland. (1995) (135)
The causes of hospital-treated acute lower respiratory tract infection in children. (1991) (135)
Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. (1990) (135)
Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer (1997) (134)
Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland. (1996) (132)
Importance of smoking for Chlamydia pneumoniae seropositivity. (1994) (124)
Pharyngitis in adults: the presence and coexistence of viruses and bacterial organisms. (1989) (120)
Radical changes to chlamydial taxonomy are not necessary just yet. (2001) (117)
Persistence of chlamydial antibodies after pelvic inflammatory disease (1986) (112)
Detection of Chlamydia pneumoniae in human nonrheumatic stenotic aortic valves. (1997) (112)
Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma (1996) (106)
Chlamydia pneumoniae multiplies in human endothelial cells in vitro. (1994) (104)
Size at birth, weight gain over the life course, and low-grade inflammation in young adulthood: northern Finland 1966 Birth Cohort study. (2008) (99)
Tick‐borne viral encephalitis in Finland. The clinical features of Kumlinge disease during 1959–1987 (1989) (93)
Bacterial antibody assays in the diagnosis of acute lower respiratory tract infection in children. (1995) (93)
Acute lower-respiratory-tract infection associated with chlamydial TWAR antibody in Filipino children. (1988) (92)
Autoimmunity to Human Heat Shock Protein 60, Chlamydia pneumoniae Infection, and Inflammation in Predicting Coronary Risk (2002) (91)
Reactivation of Chlamydia pneumoniae infection in mice by cortisone treatment (1996) (90)
Aetiology of community-acquired pneumonia in children treated in hospital (2005) (88)
Frequent Association of Chlamydial Infection with Reiter's Syndrome (1978) (87)
Epidemiology of Sindbis virus infections in Finland 1981–96: possible factors explaining a peculiar disease pattern (2002) (86)
Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14 (2002) (84)
Inhibitory effect of dietary phenolic compounds on Chlamydia pneumoniae in cell cultures. (2006) (82)
Oral empiric treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing sparfloxacin with roxithromycin. The Scandinavian Sparfloxacin Study Group. (1996) (79)
Single-antigen immunofluorescence test for chlamydial antibodies (1978) (78)
Synergistic Effect of Persistent Chlamydia pneumoniae Infection, Autoimmunity, and Inflammation on Coronary Risk (2003) (76)
Epidemiology of Chlamydia pneumoniae in atherosclerosis. (1999) (75)
Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease. (1996) (74)
Chlamydia pneumoniae reactive T lymphocytes in the walls of abdominal aortic aneurysms (1999) (74)
Chlamydia trachomatis in acute salpingitis. (1980) (73)
Chlamydia pneumoniae Inhibits Apoptosis in Human Epithelial and Monocyte Cell Lines * (2002) (73)
Pathogenic bacteria and viruses in induced sputum or pharyngeal secretions of adults with stable asthma (2006) (70)
Mannose-binding lectin concentrations, MBL2 polymorphisms, and susceptibility to respiratory tract infections in young men. (2008) (69)
Experimental infection of Chlamydia pneumoniae in mice. (1993) (69)
Chlamydia pneumoniae and atherosclerosis--an update. (1997) (67)
Can Degenerative Aortic Valve Stenosis Be Related to Persistent Chlamydia pneumoniae Infection? (1998) (66)
Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease (1997) (65)
Etiology of acute lower respiratory tract infections in children in a rural community in The Gambia (1992) (64)
Serologic markers for Chlamydia pneumoniae in asthma. (2000) (64)
Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis. (1999) (64)
Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis. (2003) (63)
Age‐specific prevalence of complement‐fixing antibodies to sixteen viral antigens: A computer analysis of 58,500 patients covering a period of eight years (2005) (62)
Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. (1993) (59)
Chlamydia pneumoniae in atherosclerosis (2000) (59)
Chlamydia pneumoniae Does Not Increase Atherosclerosis in the Aortic Root of Apolipoprotein E-Deficient Mice (2001) (58)
Measurement of sputum antibodies in the diagnosis of acute and chronic respiratory infections associated with Chlamydia pneumoniae (1995) (57)
Chlamydia pneumoniae is an important cause of community-acquired pneumonia in school-aged children: serological results of a prospective, population-based study. (1999) (57)
Chapter 13 – NEPHROPATHIA EPIDEMICA IN FINLAND (1979) (57)
Effect of Simvastatin, an Established Lipid-Lowering Drug, on Pulmonary Chlamydia pneumoniae Infection in Mice (2005) (56)
Cell-Mediated Immune Response during Primary Chlamydia pneumoniae Infection (2000) (56)
Chlamydia pneumoniae associated with central nervous system infections. (1996) (56)
Genital Chlamydia trachomatis Infections in Patients with Cervical Atypia (1979) (55)
Detection of Chlamydia trachomatis by nucleic acid sandwich hybridization (1984) (55)
The epidemic cycle of Chlamydia pneumoniae infection in eastern Finland, 1972–1987 (1993) (53)
The effect of prolonged doxycycline therapy on Chlamydia pneumoniae serological markers, coronary heart disease risk factors and forearm basal nitric oxide production. (1998) (52)
High prevalence of antibodies to Chlamydia pneumoniae; determinants of IgG and IgA seropositivity among Jerusalem residents (1995) (52)
In vivo treatment of acute Chlamydia pneumoniae infection with the flavonoids quercetin and luteolin and an alkyl gallate, octyl gallate, in a mouse model. (2005) (51)
Chlamydia trachomatis seropositivity during pregnancy is associated with perinatal complications. (1995) (50)
Chlamydia pneumoniae antibodies and serum lipids in Finnish men: cross sectional study (1997) (50)
Immunologically related ketodeoxyoctonate-containing structures in Chlamydia trachomatis, Re mutants of Salmonella species, and Acinetobacter calcoaceticus var. anitratus (1984) (50)
Experimental Chlamydia pneumoniae infection in mice: effect of reinfection and passive immunization. (1995) (49)
Chlamydia pneumoniae and acute myocardial infarction in Jerusalem. (1997) (48)
Association of infection with Chlamydia trachomatis with Fitz-Hugh-Curtis syndrome. (1981) (48)
Lymphocyte responses to Chlamydia antigens in patients with coronary heart disease. (1997) (48)
Association between Chlamydia trachomatis antibodies and subfertility in the Northern Finland Birth Cohort 1966 (NFBC 1966), at the age of 31 years (2004) (48)
Elevated MMP‐8 and Decreased Myeloperoxidase Concentrations Associate Significantly with the Risk for Peripheral Atherosclerosis Disease and Abdominal Aortic Aneurysm 1 (2010) (48)
Host immune response to Chlamydia pneumoniae heat shock protein 60 is associated with asthma. (2001) (48)
Interference of immunoglobulin G (IgG) antibodies in IgA antibody determinations of Chlamydia pneumoniae by microimmunofluorescence test (1994) (47)
Cell-mediated immunity to Chlamydia pneumoniae measured as lymphocyte blast transformation in vitro (1993) (47)
Chlamydia pneumoniae infection and the risk of female early‐onset lung cancer (2003) (46)
Prospective case-control study of role of infection in patients who reconsult after initial antibiotic treatment for lower respiratory tract infection in primary care (1997) (46)
Cross-reactivity between Chlamydiazyme and Acinetobacter strains. (1986) (45)
Epidemiologic association of Chlamydia pneumoniae and atherosclerosis: the initial serologic observation and more. (2000) (45)
Immune responses to Chlamydia pneumoniae in twins in relation to gender and smoking. (1998) (44)
Serological response to Chlamydia pneumoniae in patients with sarcoidosis. (1996) (44)
Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri. (2004) (44)
Heat shock protein 60 autoimmunity and early lipid lesions in cholesterol-fed C57BL/6JBom mice during Chlamydia pneumoniae infection. (2004) (43)
Chlamydia trachomatis in acute salpingitis. (1979) (43)
Evaluation of serological methods in the diagnosis ofChlamydia pneumoniae pneumonia during an epidemic in Finland (1993) (42)
Chlamydia pneumoniae Infection and Inflammation in Adults with Asthma (2004) (42)
Arboviruses in Finland. II. Isolation and characterization of Uukuniemi virus, a virus associated with ticks and birds. (1973) (42)
Influenza C virus infection in military recruits—symptoms and clinical manifestation (2014) (41)
Chlamydial pneumonitis and its serodiagnosis in infants. (1984) (41)
The proatherogenic properties of lipoprotein(a) may be enhanced through the formation of circulating immune complexes containing Chlamydia pneumoniae-specific IgG antibodies. (2000) (41)
Chlamydia pneumoniae and chronic lung diseases. (1997) (41)
Effect of pravastatin in mildly hypercholesterolemic young men on serum matrix metalloproteinases. (2001) (38)
Chlamydial Antibodies and Risk of Prostate Cancer (2005) (38)
Arboviruses in Finland. IV. Isolation and characterization of Inkoo virus, a Finnish representative of the California group. (1973) (38)
Serum C-reactive Protein and Chlamydia trachomatis Antibodies in Preterm Delivery (2005) (38)
Chlamydia pneumoniae community-acquired pneumonia: A review of 62 hospitalized adult patients (1996) (37)
Chlamydial serology. (1982) (36)
Discussion and Conclusion. (2018) (36)
Arboviruses in Finland. I. Isolation of tick-borne encephalitis (TBE) virus from arthropods, vertebrates, and patients. (1973) (36)
Characterization of Chlamydia pneumoniae Antigens Using Human T Cell Clones (1997) (36)
Examination of Men with Nongonococcal Urethritis and Their Sexual Partners for Chlamydia trachomatis and Ureaplasma urealyticum (1978) (36)
Chlamydial antibodies in an elderly Finnish population. (1999) (35)
Genital chlamydial infections in patients attending a gynaecological outpatient clinic. (1978) (34)
Antibodies to human heat shock protein 60, hypertension and dyslipidemia. A study of joint effects on coronary risk. (2003) (33)
Treatment of nongonococcal urethritis with trimethoprim-sulphadiazine and with placebo. A double-blind partner-controlled study. (1980) (32)
Serologic tests for Chlamydia pneumoniae. (1993) (31)
Chlamydial LPS and high-sensitivity CRP levels in serum are associated with an elevated body mass index in patients with cardiovascular disease (2008) (31)
Corn mint (Mentha arvensis) extract diminishes acute Chlamydia pneumoniae infection in vitro and in vivo. (2011) (30)
Chlamydial lipopolysaccharide (cLPS) is present in atherosclerotic and aneurysmal arterial wall--cLPS levels depend on disease manifestation. (2010) (30)
Measurement of Chlamydia pneumoniae-Specific Immunoglobulin A (IgA) Antibodies by the Microimmunofluorescence (MIF) Method: Comparison of Seven Fluorescein-Labeled Anti-Human IgA Conjugates in an In-House MIF Test Using One Commercial MIF and One Enzyme Immunoassay Kit (2003) (29)
The seroepidemiology of Chlamydiae in Finland over the period 1971 to 1987 (1989) (29)
Prevalence and Persistence of Chlamydia pneumoniae Antibodies in Healthy Laboratory Personnel in Finland (2005) (29)
Effects of Repeated Chlamydia pneumoniae Inoculations on Aortic Lipid Accumulation and Inflammatory Response in C57BL/6J Mice (2005) (29)
Chlamydial and Periodontal Pathogens Induce Hepatic Inflammation and Fatty Acid Imbalance in Apolipoprotein E-Deficient Mice (2009) (28)
Ultrastructure of Chlamydia pneumoniae in cell culture. (1991) (28)
Antibodies to Chlamydia trachomatis heat shock proteins Hsp60 and Hsp10 and subfertility in general population at age 31 (2004) (27)
Prevalence and persistence of antibodies to herpes viruses, Chlamydia pneumoniae and Helicobacter pylori in Alaskan Eskimos: the GOCADAN Study. (2006) (27)
Chlamydia trachomatis immunotypes in Finland. (2009) (26)
The inner structure of Uukuniemi and two Bunyamwera supergroup arboviruses. (1969) (26)
Novel enzyme immunoassay utilizing lipopolysaccharide-binding protein as a capture molecule for the measurement of chlamydial lipopolysaccharide in serum. (2006) (26)
Enterovirus, mycoplasma and other infections as predictors for myocardial infarction (2002) (25)
Maternal Serum Chlamydia Pneumoniae Antibodies and CRP Levels in Women with Preeclampsia and Gestational Hypertension (2008) (25)
Periodontopathogen‐ and Host‐Derived Immune Response in Acute Coronary Syndrome (2011) (25)
Association of seropositivity for Chlamydia pneumoniae and coronary artery disease in heterozygous familial hypercholesterolaemia (1999) (25)
Clinical scoring system in the evaluation of adult pharyngitis. (1993) (25)
Chronic Chlamydia pneumoniae Infections (1995) (24)
The prevalence and regional distribution of antibodies against Chlamydia pneumoniae (strain TWAR) in Finland in 1958. (1992) (24)
Risk factors for acute respiratory tract illness in military conscripts (2008) (23)
Electron microscopy of the Uukuniemi virus, an ungrouped arbovirus. (1968) (23)
Experimental Chlamydia pneumoniae infection in NIH/S mice: effect of reinoculation with chlamydial or cell preparation on culture, PCR and histological findings of lung tissue. (2002) (23)
Mosquito-borne viruses in Finland. (1975) (23)
Chlamydia pneumoniae together with collagenase-2 (MMP-8) in periodontal lesions. (2004) (23)
Humoral immune response to Chlamydia pneumoniae in twin discordant for smoking. (1998) (23)
Chlamydia pneumoniae Infection in Human Monocytes (1999) (23)
Chlamydial lipopolysaccharide is present in serum during acute coronary syndrome and correlates with CRP levels. (2007) (22)
Erythema nodosum in chlamydial infections. (1980) (22)
Solid-phase enzyme immunoassay for Chlamydial antibodies (1983) (22)
Interleukin-1B genotype modulates the improvement of coronary artery reactivity by lipid-lowering therapy with pravastatin: a placebo-controlled positron emission tomography study in young healthy men. (2003) (21)
Detection of Chlamydia pneumoniae by colorimetric in situ hybridization (1999) (21)
Bacterial infection in under school age children with expiratory difficulty (1991) (21)
High oxidized LDL and elevated plasma homocysteine contribute to the early reduction of myocardial flow reserve in healthy adults (2002) (20)
Ixodes lividus (Acari) in sand martin colonies in Fennoscandia (1977) (20)
Telithromycin Treatment of Chronic Chlamydia pneumoniae Infection in C57BL/6J mice (2004) (19)
Chlamydia antibodies and self-reported symptoms of oligo-amenorrhea and hirsutism: a new etiologic factor in polycystic ovary syndrome? (2010) (19)
The structure of Uukuniemi virus. (1970) (19)
Effects of CD14, TLR2, TLR4, LPB, and IL‐6 Gene Polymorphisms on Chlamydia pneumoniae Growth in Human Macrophages In Vitro (2009) (19)
Prevalence of Chlamydia pneumoniae specific antibodies in different clinical situations and healthy subjects in Izmir, Turkey (1998) (18)
Electron microscope study on the development of Uukuniemi virus. (1970) (18)
Severe bronchiolitis probably caused by varicella-zoster virus. (1982) (18)
Atypical respiratory pathogens (1997) (18)
Isolation of non-cubical ribonucleoprotein from Inkoo virus, a Bunyamwera supergroup arbovirus. (1971) (17)
Comparison of polymerase chain reaction methods, in situ hybridization, and enzyme immunoassay for detection of Chlamydia pneumoniae in atherosclerotic carotid plaques. (2008) (17)
Inhibitory effect of heparan sulfate-like glycosaminoglycans on the infectivity of Chlamydia pneumoniae in HL cells varies between strains. (2006) (17)
Association of Chlamydia pneumoniae Infection with HLA-B*35 in Patients with Coronary Artery Disease (2007) (16)
Treatment of acute Chlamydia pneumoniae infection with telithromycin in C57BL/6J mice. (2004) (16)
Erythromycin and lymecycline treatment in chlamydia-positive and Chlamydia-negative non-gonococcal urethritis--a partner-controlled study. (1979) (16)
Association of IL-6 and IL-6R gene polymorphisms with susceptibility to respiratory tract infections in young Finnish men. (2011) (16)
Arboviruses in Finland. 3. Uukuniemi virus antibodies in human, cattle, and reindeer sera. (1973) (15)
Infertility and cervical chlamydia trachomatis infections (1979) (15)
Collaborative multidisciplinary workshop report: interface of lipid metabolism, atherosclerosis, and Chlamydia infection. (2000) (15)
Weight at birth and infancy in relation to adult leukocyte count: a population-based study of 5619 men and women followed from the fetal period to adulthood. (2009) (15)
Association between Chlamydia pneumoniae antibodies and intimal calcification in femoral arteries of nondiabetic patients. (2002) (15)
Training Improves Physical Fitness and Decreases CRP Also in Asthmatic Conscripts (2008) (15)
Susceptibility of Human Monocyte‐macrophages to Chlamydia pneumoniae Infection In Vitro is Highly Variable and Associated with levels of Soluble CD14 and C. pneumoniae IgA and Human HSP‐IgG Antibodies in Serum (2008) (15)
THE IMPORTANCE OF CHLAMYDIA PNEUMONIAE AS A PATHOGEN: THE 1996 CONSENSUS CONFERENCE ON CHLAMYDIA PNEUMONIAE INFECTIONS (1997) (14)
Seroepidemiology in Chlamydia pneumoniae-- atherosclerosis association. (2002) (14)
Asthmatic persons are prone to the persistence of Chlamydia pneumoniae antibodies. (2007) (13)
Effects of coadministration of natural polyphenols with doxycycline or calcium modulators on acute Chlamydia pneumoniae infection in vitro (2011) (13)
Epidemiologic and Clinical Characteristics of Pelvic Inflammatory Disease Associated with Mycoplasma hominis, Chlamydia trachomatis, and Neisseria gonorrhoeae (1986) (13)
Chlamydia pneumoniae and Helicobacter pylori infections in Sámi and Finnish reindeer herders. (1997) (13)
Viruses in Ixodes Uriae (Acari: Ixodidae) from Seabird Colonies at RøSt Islands, Lofoten, Norway1 (1980) (13)
Effect of pravastatin treatment on Chlamydia pneumoniae infection, inflammation and serum lipids in NIH/S mice. (2007) (12)
Chlamydia pneumoniae antibodies associated with altered serum lipid profile. (1998) (12)
Chlamydia pneumoniae infection is associated with elevated body mass index in young men (2009) (12)
Serum chlamydial lipopolysaccharide as a prognostic factor for a new cardiovascular event. (2009) (12)
Passerine birds in the ecology of Uukuniemi virus. (1974) (11)
The effect of proatherogenic microbes on macrophage cholesterol homeostasis in apoE-deficient mice. (2011) (11)
Diagnosis of Chlamydia pneumoniae. (1998) (11)
Clinical conditions associated with positive complement fixation serology for Chlamydiae (1987) (11)
The platelet aggregation test in group B arbovirus infections (1970) (11)
Animal models for Chlamydia pneumoniae infection. (1998) (10)
Tick-borne viruses in Finland. (1975) (10)
Combination treatment in Chlamydia-triggered reactive arthritis: comment on the article by Carter et al. (2011) (10)
Effect of acute Chlamydia pneumoniae infection on lipoprotein metabolism in NIH/S mice (2002) (10)
Mycoplasma pneumoniae and Chlamydia trachomatis in acute lower respiratory infections in Filipino children. (1993) (10)
Polymerase chain reaction assay for detecting Chlamydia pneumoniae in middle ear fluid of children with otitis media with effusion. (1999) (10)
Chronic Chlamydia pneumoniae Infection Increases the Risk of Occlusion of Lumbar Segmental Arteries of Patients with Sciatica: A 3-Year Follow-up Study (2003) (9)
Comparative sensitivity of different serological tests for detecting chlamydial antibodies in perihepatitis. (1985) (9)
Hazards of expanding tourism: report of six cases of Q fever in Finland. (1974) (9)
Beneficial effect of clarithromycin in patients with acute coronary syndrome and complement C4 deficiencies (2009) (9)
Rapamycin can Inhibit the Development of Chlamydia pneumoniae, which Might Partly Contribute to the Prevention of In-stent Restenosis (2010) (9)
Letters to the EditorCYTOMEGALOVIRUS HEPATITIS (1967) (8)
Antibodies to Chlamydia trachomatis in serum and peritoneal fluid of women with endometriosis (2011) (8)
The association of body mass index, waist and hip circumference, and waist–hip ratio with Chlamydia pneumoniae IgG antibodies and high-sensitive C-reactive protein at 31 years of age in Northern Finland Birth Cohort 1966 (2011) (8)
Chlamydia pneumoniae DNA is present in peripheral blood mononuclear cells during acute coronary syndrome and correlates with chlamydial lipopolysaccharide levels in serum (2009) (8)
IMPORT OF PSITTACINE BIRDS AND CHLAMYDIAL INFECTIONS IN FINLAND (1988) (8)
Low mannose-binding lectin levels and MBL2 gene polymorphisms associate with Chlamydia pneumoniae antibodies (2011) (8)
Chlamydial infection and reactive airway disease. (1995) (8)
The effect of proatherogenic pathogens on adipose tissue transcriptome and fatty acid distribution in apolipoprotein E-deficient mice (2013) (7)
Blackbird, Turdus merula L., and tick-borne encephalitis (TBE) virus. (1973) (7)
Direct detection of Chlamydia trachomatis in clinical samples. (1985) (7)
Chlamydia pneumoniae antibody levels before coronary events in the Helsinki Heart Study as measured by different methods. (2006) (7)
Early diagnosis of tick-borne encephalitis (TBE) by demonstration of specific IgM antibodies. (1978) (7)
Rapid genotyping of lipopolysaccharide-binding protein (LBP) C(1341)-->T (Leu(436)-->Phe) polymorphism by LightCycler real-time PCR. (2006) (7)
Chlamydia pneumoniae and luminal narrowing after coronary angioplasty (2001) (7)
Acute Chlamydia pneumoniae infections in asthmatic and non-asthmatic military conscripts during a non-epidemic period. (2008) (6)
Quantification of Chlamydia pneumoniae in cultured human macrophages and HL cells: comparison of real‐time PCR, immunofluorescence and ELISA methods (2010) (6)
Processing of McCoy cell cultures infected with Chlamydia trachomatis: sequential isolation of chlamydial elementary bodies and lipopolysaccharide (1984) (6)
Interleukin‐6 −174 G/C Promoter Polymorphism is Associated with Persistence of Chlamydia pneumoniae Antibodies in Young Men (2011) (6)
Peripheral blood monocytes from patients with reactive arthritis show normal production of tumour necrosis factor‐alpha (1991) (6)
Stillbirths and maternal antibodies to Chlamydia trachomatis. A new EIA test for serology (1996) (6)
Chlamydia pneumoniae Infection Among Healthy Children and Children Hospitalised with Pneumonia in Greece (2002) (6)
Chlamydia trachomatis infection is a risk factor for cervical cancer (2000) (6)
CHLAMYDIA TWAR AND ACUTE MYOCARDIAL INFARCTION (1989) (5)
Chlamydia pneumoniae and cardiovascular diseases. (1996) (5)
Higher prevalence of Chlamydia pneumoniae seropositivity in Finnish twins compared with co-twins living in Sweden: relationships with markers of subclinical atherosclerosis. (2003) (5)
Chlamydia trachomatis inacutesalpingitis (1979) (5)
Selective cyclooxygenase inhibitors prevent the growth of Chlamydia pneumoniae in HL cells. (2008) (4)
Comparison of culture, enzyme immunoassay and nucleic acid sandwich hybridization in detecting Chlamydia trachomatis in genital tract infections (1988) (4)
PO1-20 CHRONIC CHLAMYDIA PNEUMONIAE INFECTION INDUCES LIVER STEATOSIS IN APOE-DEFICIENT MICE (2007) (4)
Classification and new developments in the pathogenesis of vasculitis (2005) (4)
[Cytomegalovirus hepatitis and pericarditis]. (1968) (4)
Longitudinal biobanks-based study on the joint effects of infections, nutrition and hormones on risk of prostate cancer (2016) (3)
Problems in Diagnosis of Chronic Chlamydia pneumoniae Infections (1991) (3)
Intragastric primary infection sensitizes to lung reinfection in a Chlamydia pneumoniae mouse model. (2008) (3)
[The ultrastructure of a new species of Chlamydia--Chlamydia pneumoniae]. (1992) (3)
Increased prostanoid dependency of arterial relaxation in Chlamydia pneumoniae-infected mice. (2006) (3)
Methodological aspects affecting the infectivity of Chlamydia pneumoniae in cell cultures in vitro. (2005) (3)
Pivampicillin Versus Doxycycline in the Treatment of Chlamydial Urethritis in Men (1990) (3)
Chlamydophila pneumoniae antibodies in office workers with and without inflammatory rheumatic diseases in a moisture-damaged building (2005) (2)
IgG subclass-specific antibodies in Chlamydia pneumoniae infections. (1998) (2)
Occurrence of influenza A viruses and their antibodies in migratory birds in Finland. (1980) (2)
Chlamydia pneumoniae and atherosclerosis (1999) (2)
Relation of C pneumoniae antibodies to ischaemic heart disease. Finnish study finds significant association between raised IgG, but not IgA, titres and mortality. (1999) (2)
Chlamydia pneumoniae--a new important respiratory pathogen. (1991) (1)
Role of Infection in the Pathogenesis of Coronary Artery Disease (1998) (1)
Mo-P2:176 Correlation between circulating chlamydial lipopolysaccharide and CRP levels during acute coronary syndrome (2006) (1)
[Chlamydia trachomatis and Neisseria gonorrhoeae in acute salpingitis]. (1979) (1)
Measurement of Chlamydia pneumoniae-specific immunoglobulin A (IgA) antibodies by the microimmunofluorescence (MIF) method: Comparison of seven fluorescein-labeled anti-human IgA conjugates in an in-house MIF and one enzyme immunoass (2003) (1)
[Chlamydias--the Cinderella story of infectious diseases]. (2000) (1)
Association of Helicobacter pylori in infection with elevated lipids (1999) (1)
Chlamydia pneumoniaeDoes Not Increase Atherosclerosis in the Aortic Root of Apolipoprotein E–Deficient Mice (2001) (1)
Enzyme immunoassay and enzyme-linked fluoroimmunoassay for detection ofChlamydia trachomatis antigen (1987) (1)
Erratum: Radical changes to chlamydial taxonomy are not necessary just yet (International Journal of Systematic and Evolutionary Microbiology (2006) vol. 51 (249)) (2006) (1)
PO9-206 PERIODONTOPATHOGEN- AND HOST-DERIVED IMMUNE RESPONSE IN ACUTE CORONARY SYNDROME (2007) (0)
[Chlamydiaceae and cancer]. (1999) (0)
ASCLS 2002 Annual Meeting: Official Abstracts of Submitted Papers and Posters (2002) (0)
Kirsi Monocytes Infection in Human Chlamydia pneumoniae (1998) (0)
INFLAMMATION INDUCED BY PROATHEROGENIC MICROBES PROMOTES FOAM CELL FORMATION BY INCREASING INFLUX AND REDUCING EFFLUX IN APOE-DEFICIENT MICE (2008) (0)
Abstract: P659 PROATHEROGENIC PATHOGENS REDUCE THE PUFA/SFA RATIO IN ADIPOSE TISSUES IN APOE-DEFICIENT MICE (2009) (0)
PSITTACINE BIRDS AND CHLAMYDIA (1988) (0)
A method for the treatment and diagnosis of ischemic heart disease. (1989) (0)
perihepatitis . detecting chlamydial antibodies in different serological tests for Comparative sensitivity of Väänänen and (2004) (0)
1P-0119 Effect of Chlamydia pneumoniae (Cpn) infection, inflammation and the factors of metabolic syndrome on coronary risk in the Helsinki heart study (HHS) (2003) (0)
2WS13-1 Infections and atherosclerosis — Is serology useful? (2003) (0)
Chlamydia Pneumoniae and Aggregatibacter Actinomycetemcomitans Are Recovered and Induce Pro-Inflammatory Gene Expression in the Liver of Apoe-Deficient Mice (2008) (0)
Birth weight and adult low grade inflammation in a cohort followed from the fetal period to adulthood: Results from the 1966 Northern Finland Birth Cohort study (2005) (0)
Moving beyond unfractionated heparin for acute coronary syndromes: Xeno’s Paradox revisited (2002) (0)
Host immune response to Chlamydia pneumoniae heat shock protein 60 is associated with asthma Host immune response to pneumoniae protein is associated with (2001) (0)
Infections and atherosclerosis—is serology useful? (2004) (0)
Consistence between infection and atherosclerosis (2000) (0)
Microbiology and Epidemiology of Mycoplasma pneumoniae and Chlamydia pneumoniae in Normal and Asthmatic Subjects (2003) (0)
The effect of acute chlamydia pneumoniae infection and statin therapy on lipid metabolism in mice (2001) (0)
1.3 Animal models for Chlamydia pneumoniae infection (2000) (0)
The use in the manufacture of plant phenolic compounds in the treatment of chlamydial infection and in prophylaxis of a pharmaceutical product, health positively affect the nutritional composition or a composition for addition to foods such (2000) (0)
infection in mice by cortisone treatment. Reactivation of Chlamydia pneumoniae (2013) (0)
New Approaches in the Etiological Diagnosis of Acute Chlamydia pneumoniae Infections (1991) (0)
[Isn't chlamydia the cause of atherosclerosis?]. (2005) (0)
3.3.1 Chlamydia pneumoniae in atherosclerosis (2000) (0)
Comparative sensitivity ofdifferent serological tests fordetecting chlamydial antibodies inperihepatitis (1985) (0)
Inhibition potential of natural based products against Chlamydia pneumoniae infection (2006) (0)
Prepare Foer anvaendning at Chlamydia diagnostik (1982) (0)
Chlamydia pneumoniae and heart disease (1998) (0)
Foerfarande Foer Treatment of koronarkaerlsjukdom. (1988) (0)
Diagnosis of Chalmydia pneumoniae (1998) (0)
[Cold and infections]. (2005) (0)
Chlamydia pneumoniae infection is associated with HLA-B⁎35 in patients with coronary artery disease (2007) (0)
MHC-related risk markers for coronary artery disease—Special emphasis on C4 (2009) (0)
Introduction to the supplement from C. pneumoniae workshop November 1995 (1997) (0)
The effect of proatherogenic pathogens on adipose tissue transcriptome and fatty acid distribution in apolipoprotein E-deficient mice (2013) (0)
[Erythema nodosum associated with Chlamydia infections]. (1979) (0)
Solid-Phase EnzymeImmunoassay forChlamydial Antibodies (1983) (0)
PROATHEROGENIC PATHOGENS REDUCE THE PUFA/SFA RATIO IN ADIPOSE TISSUES IN APOE-DEFICIENT MICE (2013) (0)
Animal models for Chylamydia pneumoniae infection (1998) (0)
Is coronary heart disease an infectious disease (1998) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Pekka A. Saikku?

Pekka A. Saikku is affiliated with the following schools: